Page 131 - Cascade_Biocatalysis_Integrating_Stereoselective_and_Environmentally_Friendly_Reactions
P. 131

5.2 Physiological Cascade Reactions Involving P450s  107

               [64, 65]. N-Desmethyl- and 4-hydroxy-tamoxifen were used to examine the secondary
               metabolism of tamoxifen. N-Desmethyl-tamoxifen was predominantly biotrans-
               formed to α-hydroxy-, N-desmethyl-, N-didesmethyl-, and 4-hydroxy-N-desmethyl-
               tamoxifen (endoxifen). 4-Hydroxytamoxifen was converted to 3,4-dihydroxyta-
               moxifen and endoxifen. Among all the mentioned reactions, only the oxidation
               of N-desmethyl-tamoxifen to 4-hydroxyl-N-desmethyltamoxifen (endoxifen) was
               exclusively catalyzed by CYP2D6. All other reactions of the secondary metabolism of
               tamoxifen were catalyzed predominantly by the CYP3A enzymes (Scheme 5.17) [66].
                In analogy to exogenous substances, endogenous compounds such as steroids
               (see above), prostaglandins, and vitamins are metabolized by several P450s in
               multiple steps. One example that is particularly worth mentioning is the metabolism
               of vitamin D3. Vitamin D3 is a secosteroid involved in a wide variety of biological
               functions in humans [67]. It shows no hormonal activity itself, but is converted into
               its active form by several P450 enzymes.
                The first hydroxylation at the C25 position is mediated by mitochondrial CYP27A1
               [68] and microsomal CYP2R1 [69] during liver passage and yields 25-hydroxyvitamin
               D3. The following hydroxylation at the C1 position of 25-hydroxyvitamin D3
               catalyzed by mitochondrial CYP27B1 occurs in the kidney (Scheme 5.18) [70]. The
               resulting biologically active form of vitamin D3, namely 1α,25-dihydroxyvitamin
               D3, is widely recognized as a regulator of calcium and phosphorous metabolism
               and possesses antiproliferative and anti-invasive activities in prostate cancer cells
               [67, 71]. Moreover, it was shown that CYP27A1 can produce 1α,25-dihydroxyvitamin
               D3 from vitamin D3 via 25-hydroxy-vitamin D3 [72–74].

                                                          25                        25
                                                            OH                        OH


                              CYPs 27A1/2R1            CYPs 27A1/27B1
                                CYP105A1                 CYP105A1



               HO                      HO                        HO      1 OH

                  Vitamin D 3             25-Hydroxyvitamin D 3   1α,25-Dihydroxyvitamin D 3

               Scheme 5.18 Metabolism of vitamin D3 by hydroxylations.

                Interestingly, bacterial CYP105A1 from Streptomyces griseolus was found to
               convert vitamin D3 directly into its active form 1α,25-dihydroxyvitamin D3 via
               two oxidations, first at position C25 and then at C1 [75]. The C25-hydroxylation
               activity of CYP105A1 toward vitamin D3 and 1-(R)-hydroxylation toward 25-
               hydroxyvitamin D3 were much lower than those of CYP27A1 (v  = 16 nmol/nmol
                                                               max
               (P450)/min vs 270 mol/nmol (P450)/min, and 3.6 mol/nmol (P450)/min vs
               21 mol/nmol (P450)/min respectively). Site-directed mutagenesis at positions
               R73 and or R84 highly enhanced both 1-(R)- and 25-hydroxylation activities
   126   127   128   129   130   131   132   133   134   135   136